In this episode, Kieron Scrutton joins Florian Schnappauf to discuss architecting an AI-ready enterprise to achieve commercial efficiency at scale. Discover why prioritizing speed and a zero-disruption allowed GSK to move quickly to a next-generation platform with AI embedded to support its ambition of impacting 2.5 billion patients by 2030. Kieron shares how to identify high-value business processes for AI investment and the importance of role-specific training and data-driven decisions.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from What Pharma Needs Next
UCB and Takeda: Improving the Customer Experience through Medical-Commercial Collaboration
Turning Content into Memorable Customer Experiences
Preparing for a Faster Trial-to-Treatment Pathway
Preparing for a Launch: Pharma's High-Stakes Gamble
Get summaries like this every morning.
Free AI-powered recaps of What Pharma Needs Next and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.